Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 23;2018:1425707. doi: 10.1155/2018/1425707

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Jianqing Li et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

The long-term (12 months) efficacy comparison among three subtypes of neovascular age-related macular degeneration (nAMD) was presented. (a) Vision improvement, evaluated by Early Treatment of Diabetic Retinopathy Study (ETDRS) letters, were 6.38 (95% CI: 4.62, 8.14), 8.12 (95% CI: 6.29, 9.95), and 9.73 (95% CI: 7.85, 11.61) for the three types of nAMD. (b) Macular thickness changes were −126.51 (95% CI: −167.58, −85.43), −126.52 (95% CI: −150.99, −102.05), and −139.85 (95% CI: −203.43, −76.28) μm, respectively.